SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000914475-21-000062
Filing Date
2021-11-22
Accepted
2021-11-22 08:01:34
Documents
13
Period of Report
2021-11-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20211122.htm   iXBRL 8-K 41254
2 EX-99.1 nbix-20211122exhibit991.htm EX-99.1 30438
  Complete submission text file 0000914475-21-000062.txt   218402

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20211122.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20211122_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20211122_pre.xml EX-101.PRE 12512
6 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20211122_htm.xml XML 10821
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

IRS No.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 211430196
SIC: 2836 Biological Products, (No Diagnostic Substances)